Uncategorised - European Medical Journal

Adjuvant Nivolumab in MIBC: Lessons from CheckMate 274

New analysis reveals nivolumab’s impact on disease-free survival in high-risk muscle-invasive bladder cancer.

Mohs Surgery Alone Outperforms Combo With Photodynamic Therapy

New research suggests that Mohs micrographic surgery (MMS) alone may lead to lower recurrence rates than when combined with photodynamic therapy (PDT) in treating locally advanced basal cell carcinoma (laBCC), particularly in non-aggressive subtypes.

Lower Transfusion Thresholds May Be Safe for Children Post-Transplant

A new UK clinical trial has found that children undergoing stem cell transplants may safely receive fewer blood transfusions.

Trial Shows No Added Benefit From Antibiotics Before Appendectomy

A large randomized clinical trial suggests that adults with uncomplicated appendicitis can safely wait for surgery without receiving antibiotics.

Social media interaction icons

Social media key to Gen Z pharma hires, says ABPI

According to new research from the ABPI, pharma companies need to modernise their outreach strategies.

Is Short-Course Tuberculosis Treatment Ready for Practice?

Participants were randomised to receive either the WHO-recommended 24-week standard regimen or one of four novel 8-week regimens.

ERA 2025: Higher-Dose Canagliflozin Yields Greater Cardiovascular Protection in High-Risk Patients

A post-hoc analysis of the CANVAS trial reveals a dose-dependent cardiovascular benefit with canagliflozin in type 2 diabetes, while kidney protection appears consistent across doses.

Waist-to-Hip Ratio Strongly Linked to Psoriasis

The results revealed that central adiposity, fat concentrated around the waist and abdomen, had the strongest link to psoriasis.

EASL Congress 2025 Interview: Aleksander Krag

What we set out to do, and what we’ve continued working on, is exploring all the ways we could create the best possible Congress…

Structural Valve Deterioration After TAVI: What Clinicians Need to Know

Long-term study shows low incidence of structural valve deterioration after TAVI, guiding clinical care.